Welcome to PsychU!

Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics

Loading Events

Thank You For Attending Today’s Webinar

Please tell us what you thought about today’s presentation by taking the survey below:

Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar I Disorder: The Role Of Long-Acting Injectable Antipsychotics

This is a Virtual Event for PsychU members in Maryland, DC, Virginia, North Carolina, and South Carolina.

Bipolar I Disorder is characterized by mood episode recurrence, which impacts patient functioning and clinical outcomes. During our discussion, the speakers will discuss risk factors for mood recurrence including non-adherence. They will also discuss some management strategies including long acting injectables (LAIs) that may optimize patient outcomes.

Featuring

Dennis-Sholler

Dennis Sholler, PhD (OPDC)

Clinical & Scientific Liaison

Amica-Simmons-Yon

Amica Simmons-Yon, PharmD, PhD (OPDC)

Clinical & Scientific Liaison

Miranda-Fisher

Miranda Fisher, PhD (OPDC)

Clinical & Scientific Liaison

Speakers Dennis Sholler, PhD; Amica Simmons-Yon, PharmD, PhD; and Miranda Fisher, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)

Registration

Related Resources